DAnalysis of the Distribution of Adrenal Steroids in a Control Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-02-28

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a biomedical research study on the determination of adrenal steroids. It has been proposed in recent years as a tool for the diagnostic orientation of an adrenal pathology. The main objective is to analyze the distribution of blood and urinary adrenal steroid values in a population of 60 controls. The secondary objective is to establish reference values for each of these parameters, if their distribution permits, and to study the possible link between the blood pressure level, the orthostatism state, the potassium level and these adrenal steroids.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk of Positive Doping Tests Following Ingestion of Supplements Contaminated With Trace Quantities of Nandrolone Metabolites

NCT00682123

Positive Doping Tests in Sports

COMPLETED PHASE1/PHASE2

Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls

NCT04791345

Healthy Volunteers

UNKNOWN PHASE1

Beclomethasone in Healthy Athletes

NCT05352191

Performance, Detection Doping

UNKNOWN PHASE4

Generation of Biological Samples Positive to Triptorelin for Anti-doping Control

NCT04189900

Healthy Volunteers

COMPLETED PHASE1

Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.

NCT04757532

Healthy Volunteers

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adrenal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy subjects

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Negative blood pregnancy test
* Normosalt diet
* Men and women ≥ 18 years
* Being able and willing to give written informed consent

Exclusion Criteria

* Personal history of diabetes, high blood pressure, adrenal pathologies.
* Family history of adrenal pathologies.
* Taking of the following drugs:

Antihypertensives drugs: ACE inhibitor, Angiotensin II receptor, beta-blocker, thiazide diuretic, loop diuretic, anti-aldosterone, dihydropyridine-type calcium antagonist.

* Hormone replacement therapy, cyproterone acetate
* NSAID (except occasional intake), corticosteroid
* Antidepressant: serotonin reuptake inhibitor (paroxetine, fluoxetine, sertraline, citalopram)
* Contraception or estrogen / progestin treatment (progestins only allowed)
* Not be able to keep standing position.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes